2-Oxa-6-azaspiro[3.4]octane, 95%, Thermo Scientific Chemicals
2-Oxa-6-azaspiro[3.4]octane, 95%, Thermo Scientific Chemicals
Thermo Scientific Chemicals

2-Oxa-6-azaspiro[3.4]octane, 95%, Thermo Scientific Chemicals

Have Questions?
Change viewbuttonViewtableView
Quantity:
500 mg
250 mg
Catalog number H57579.ME
also known as H57579-ME
Price (USD)/ Each
685.00
-
Add to cart
Quantity:
500 mg
Request bulk or custom format
Price (USD)/ Each
685.00
Add to cart
2-Oxa-6-azaspiro[3.4]octane, 95%, Thermo Scientific Chemicals
Catalog numberH57579.ME
Price (USD)/ Each
685.00
-
Add to cart
Specifications
Chemical Name or Material2-Oxa-6-azaspiro[3.4]octane
CAS220290-68-6
Health Hazard 1H227-H315-H319-H335
Health Hazard 2GHS H Statement
H315-H319-H335-H227
Causes skin irritation.
Causes serious eye irritation.
May cause respiratory irritation.
Combustible liquid.
Health Hazard 3P210-P235-P261-P264b-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P332+P313-P362-P370+P378q-P501c
View more
2-Oxa-6-azaspiro[3.4]octane is involved in the preparation of azaspirocycle or azetidine substituted 4-anilinoquinazoline derivatives, which exhibits epidermal growth factor receptor (EGFR) inhibitory activities.

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Applications
2-Oxa-6-azaspiro[3.4]octane is involved in the preparation of azaspirocycle or azetidine substituted 4-anilinoquinazoline derivatives, which exhibits epidermal growth factor receptor (EGFR) inhibitory activities.

Solubility
Soluble in water.

Notes
Incompatible with strong oxidizing agents, strong acids, reducing agents and bases.
RUO – Research Use Only
Zhao, F.; Lin, Z.; Wang, F.; Zhao, W.; Dong, X. Four-membered heterocycles-containing 4-anilino-quinazoline derivatives as epidermal growth factor receptor (EGFR) kinase inhibitors. Bioorg. Med. Chem. Lett. 2013, 23 (19), 5385-5388.